Skip to content

Haemonetics HAE Hospital — Goodwill

Other segment segments

Plasma
$29.04M0.0%
Blood Center
$26.89M-0.3%

Similar metrics at other companies

National Healthcare logo
NHCInpatient Services — Goodwill
$5.92M0.0%
Tenet Healthcare logo
THCHospital Operations — Goodwill
$2.7B0.0%
ExlService Holdings logo
EXLSHealthcare and Life Sciences — Goodwill
$189.57M0.0%
GHC
GHCHealthcare — Goodwill, Gross
$136.64M+1.2%
Webster Financial Corporation logo
WBSHealthcare Financial Services — Goodwill
$316.07M
Universal Health Services logo
UHSAcute Care Services — Goodwill
$529.88M0.0%

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's hospital — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's hospital — goodwill?
Haemonetics (HAE) reported hospital — goodwill of $600.44M in Q1 2026.
How has Haemonetics's hospital — goodwill changed year-over-year?
Haemonetics's hospital — goodwill increased by 9.5% year-over-year, from $548.26M to $600.44M.
What does hospital — goodwill mean?
Reflects the intangible asset value recorded when the purchase price of a hospital-related acquisition exceeds the fair value of its identifiable net assets. It serves as a proxy for the premium paid for expected future synergies and market presence in the hospital sector.